: ( ) ( ), , , , , , , , ( ), , , (/ L-), , , , B1, , B6, B2, D
Volker Spitzer and Sarah Rickwood, explores: - How GLP-1 therapies affect nutrient intake and absorption - The potential consequences of deficiencies - Practical, evidence-based strategies to safeguard patient health Download the whitepaper today to understand why nutrition is not only supportive, but essential, to the future of obesity management: #ConsumerHealthcare #Obesity #GLP1 #Nutrition #MedicalNutrition Thank God someone wrote about that According to a recent UNICEF report: 60% of adults and 31% of children could be classified as overweight or obese by 2050, if current trends continue
One user specifically noted losing 23 pounds and said "the constant battle with food is finally over." These results align with what clinical data shows for semaglutide appetite suppression , suggesting the compounded medications are working for at least some percentage of users
The FDA approved the Wegovy pill based on the OASIS clinical trials and SELECT cardiovascular outcomes